2011 Lotus Evora 2+2 Only 4k Original Miles Navigation Tech Pkg Fac Warranty on 2040-cars

Auto blog

Join XCAR as it explores the history behind the Lotus Seven

All modern Caterhams are based on the Lotus Seven – a small, lightweight roadster developed by Colin Chapman back in 1957. That car has evolved into an entire range of models, spanning from the new, affordable 160, shown below in the latest video from XCAR, to the maniacal 620R. Over the years, the Seven has come to be a known quantity among auto enthusiasts. What isn't as well known is the origin of the Seven and the cars that came before it. As XCAR points out, "What happened to [the Seven's] earlier ancestors? What happened to the Lotus numbered one through six?" The answer probably isn't what you'd expect. Scroll down for a great look at unique motorsport that inspired Colin Chapman's earliest efforts in the latest video from XCAR. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Related Gallery Caterham Seven 160 View 12 Photos News Source: XCARFilms via YouTube Lotus Convertible Performance Classics xcar

Lotus Evora 400 Roadster won't save the brand, and that's okay

There may not be a more disappointing brand in the United States than Lotus. It's not because the British brand can't make a good car. In fact, it's quite the opposite. The big problem with Lotus is that it builds highly compelling cars, but can't actually sell them in America because it can't afford to make them meet the complicated set of safety requirements required by US regulators. That makes us sad. Fortunately, there's one upcoming exception. For 2017, Lotus is bringing the Evora 400 to our shores, and a North American version of the Sport 410 has been promised. We welcome them with open arms and a proper pair of Southcombe driving gloves. But that one model line isn't going to be enough to keep Lotus in the minds and hearts of driving enthusiasts from sea to shining sea, nor will it keep the admittedly small number of US dealers happy. As pleased as we are to see reports that a Roadster version of the latest Evora is on the way, more will be needed. Lotus told Autocar that it expects the convertible to account for half of its sales here in the States, and we don't doubt that. But it's still just another version of the same automobile, and 500-700 additional sales is not going to be enough to reestablish Lotus as a legitimate sportscar contender here in America. For that, it's going to need another model line or two, hopefully at an entry-level pricepoint. A range-topping halo car wouldn't hurt, either. On the bright side, the Evora Roadster sounds like a solid step in the right direction. It's apparently just as stiff and lightweight as the coupe – "It's so simple it makes you wonder why it wasn't done six years ago," says Lotus chief Jean-Marc Gales – and that means its 400-horsepower, supercharged V6 engine will still propel it from 0-60 in 4.1 seconds and to a top speed of 186 miles per hour. Plus, the Lotus name is well established and highly respected. We don't think we're smarter than the men and women leading Lotus in the UK. So, we're sure Lotus doesn't expect the Evora Roadster to completely reverse its unfortunate fortunes in the States. The promise of a new Elise in 2020 ought to help in that regard, assuming it will be more attainable than the $90,000 Evora. In the meantime, we can't wait to feel that familiar wind-in-the-hair excitement we're sure the Lotus Evora Roadster will provide.

Kimi Raikkonen to miss rest of season for back surgery

Formula One drivers keep themselves in peak physical condition, such are the demands placed on them in order to do what they do. But otherworldly as their capabilities may be, they're still human, and that means they get injured or sick just like the rest of us.
Case in point: Kimi Raikkonen and the announcement made today by Lotus that he'll have to sit out the rest of the season in order to undergo back surgery. That means Lotus will have to find a replacement driver for the last two races in Austin and Brazil while Kimi has and recovers from the operation.
Though we wouldn't debate the legitimacy of Kimi's condition or the necessity to rectify it, the timing is sure to raise some eyebrows. Raikkonen has been at the center of a pay dispute with Lotus, and while the situation was reportedly resolved, his decision to undergo what is said to be elective surgery at this point in the season (as opposed to waiting until its end) raises some questions as to his commitment to the team he is leaving and his team's financial commitments to him in turn.